Experience with sorafenib and the elderly patient View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2010-12

AUTHORS

Janice P. Dutcher, Nizar Tannir, Joaquim Bellmunt, Bernard Escudier

ABSTRACT

Renal cell carcinoma primarily affects older individuals. Approximately half of all new renal cell carcinoma diagnoses are made in persons 65 years of age or older. Devising a treatment plan for the elderly patient population requires special consideration. Age-related physiological, cognitive, and social characteristics of elderly patients may influence each stage of patient care. Until recently, treatment options were limited for elderly patients with renal cell carcinoma. Sorafenib is the first multikinase inhibitor approved for use in renal cell carcinoma in the United States and Europe. In the phase III Treatment Approaches in Renal Cell Cancer Global Evaluation Trial, sorafenib significantly extended progression-free survival in patients with advanced renal cell carcinoma, regardless of age. Incidence rates of adverse events were not significantly higher in elderly patients receiving sorafenib than in younger patients. Thus, sorafenib represents an important treatment option for elderly patients with renal cell carcinoma. This report describes particular considerations for physicians to be aware of when choosing a treatment regimen for their elderly patients with renal cell carcinoma and offers recommendations on how to integrate specific management strategies into clinical practice that will optimize the use of sorafenib in the elderly. The strategies focus on patient selection, assessment of quality of life, management of adverse events, and appropriate dose modifications. The goal of these recommendations is to maximize the clinical benefit of sorafenib in the elderly patient population through appropriate use. More... »

PAGES

1359-1370

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s12032-009-9388-4

DOI

http://dx.doi.org/10.1007/s12032-009-9388-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1002519393

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/20043216


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Benzenesulfonates", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Renal Cell", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Clinical Trials, Phase III as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kidney Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Niacinamide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phenylurea Compounds", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pyridines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Quality of Life", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Randomized Controlled Trials as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sorafenib", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Rate", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Department of Oncology, Montefiore Medical Center-North Division/New York Medical College, 600 East 233rd Street, 10466, Bronx, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dutcher", 
        "givenName": "Janice P.", 
        "id": "sg:person.0760406720.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0760406720.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, 77030, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tannir", 
        "givenName": "Nizar", 
        "id": "sg:person.01004561122.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01004561122.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hospital Del Mar", 
          "id": "https://www.grid.ac/institutes/grid.411142.3", 
          "name": [
            "Department of Genitourinary and Gastrointestinal Tumor Oncology, Hospital Del Mar, 08003, Barcelona, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bellmunt", 
        "givenName": "Joaquim", 
        "id": "sg:person.01174264563.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174264563.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Immunotherapy Unit, Institut Gustave Roussy, 94805, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Escudier", 
        "givenName": "Bernard", 
        "id": "sg:person.01304252172.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01304252172.82"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1097/00000658-198910000-00008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003070692"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000658-198910000-00008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003070692"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1569-9056(08)60692-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003933990"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmra050100", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004833991"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmra050100", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004833991"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00004872-200311000-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006591110"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00004872-200311000-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006591110"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.24864", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008293686"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.24864", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008293686"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10238-007-0145-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011346859", 
          "https://doi.org/10.1007/s10238-007-0145-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10238-007-0145-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011346859", 
          "https://doi.org/10.1007/s10238-007-0145-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.10.976", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012142576"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archderm.144.7.886", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012999259"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/djn319", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015009768"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00002512-200724050-00004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015726241", 
          "https://doi.org/10.2165/00002512-200724050-00004"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2007.15.6331", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016398351"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.19.5511", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017988502"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00114219", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018948431", 
          "https://doi.org/10.1007/bf00114219"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejca.2007.06.001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020678878"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0021-9681(87)90171-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020988115"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/path.2122", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021696329"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2230.2006.02223.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023690834"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf03324236", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024440962", 
          "https://doi.org/10.1007/bf03324236"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.23.4823", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024805447"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa060655", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025111240"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1464-410x.2007.07486.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025646383"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000227118", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027938996"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0895-4356(99)00098-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028392244"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1634/theoncologist.2008-0131", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032131308"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.thorsurg.2014.12.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032347522"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1445-5994.2007.01269.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032610540"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1532-5415.51.3s.4.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039042475"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.critrevonc.2008.08.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041881420"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2190/uurl-2ryu-wryd-ey3k", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043088486"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2190/uurl-2ryu-wryd-ey3k", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043088486"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2190/uurl-2ryu-wryd-ey3k", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043088486"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.285.23.2987", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043181545"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejca.2007.08.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044272511"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00045391-200307000-00010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045019789"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00045391-200307000-00010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045019789"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0749-0690(02)00047-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045864790"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3816/cgc.2009.n.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046305670"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.eururo.2006.10.025", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047365003"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1535-7163.mct-08-0013", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048133345"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jaad.2006.10.032", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049933957"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2190/6ncr-8ewf-tvhw-03c7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053989460"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2190/6ncr-8ewf-tvhw-03c7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053989460"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/geront/9.3_part_1.179", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059635232"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1188/07.cjon.649-656", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064136236"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.5489/cuaj.67", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1072921435"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/107327480701400103", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1077354991"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/107327480701400103", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1077354991"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2010-12", 
    "datePublishedReg": "2010-12-01", 
    "description": "Renal cell carcinoma primarily affects older individuals. Approximately half of all new renal cell carcinoma diagnoses are made in persons 65\u00a0years of age or older. Devising a treatment plan for the elderly patient population requires special consideration. Age-related physiological, cognitive, and social characteristics of elderly patients may influence each stage of patient care. Until recently, treatment options were limited for elderly patients with renal cell carcinoma. Sorafenib is the first multikinase inhibitor approved for use in renal cell carcinoma in the United States and Europe. In the phase III Treatment Approaches in Renal Cell Cancer Global Evaluation Trial, sorafenib significantly extended progression-free survival in patients with advanced renal cell carcinoma, regardless of age. Incidence rates of adverse events were not significantly higher in elderly patients receiving sorafenib than in younger patients. Thus, sorafenib represents an important treatment option for elderly patients with renal cell carcinoma. This report describes particular considerations for physicians to be aware of when choosing a treatment regimen for their elderly patients with renal cell carcinoma and offers recommendations on how to integrate specific management strategies into clinical practice that will optimize the use of sorafenib in the elderly. The strategies focus on patient selection, assessment of quality of life, management of adverse events, and appropriate dose modifications. The goal of these recommendations is to maximize the clinical benefit of sorafenib in the elderly patient population through appropriate use.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s12032-009-9388-4", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1094524", 
        "issn": [
          "1357-0560", 
          "1559-131X"
        ], 
        "name": "Medical Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "27"
      }
    ], 
    "name": "Experience with sorafenib and the elderly patient", 
    "pagination": "1359-1370", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "0bfed4032cbdfd35c90d0cd666b692d6a20949bf4c3ac782a1aae64baac82e48"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "20043216"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9435512"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s12032-009-9388-4"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1002519393"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s12032-009-9388-4", 
      "https://app.dimensions.ai/details/publication/pub.1002519393"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T09:57", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000347_0000000347/records_89812_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs12032-009-9388-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12032-009-9388-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12032-009-9388-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12032-009-9388-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12032-009-9388-4'


 

This table displays all metadata directly associated to this object as RDF triples.

300 TRIPLES      21 PREDICATES      89 URIs      39 LITERALS      27 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s12032-009-9388-4 schema:about N078886f7a28c49118027de64a424f1eb
2 N0c86e6c4f55d47dc9179e698ab59dbfe
3 N43da09f675734fb4baec683531b5f572
4 N57d5122fc74143048bcb0a7cbf27342f
5 N6689461dc36644e49bf3bdcb6688d8fa
6 N85bddf66b6f54f18b9312509543b478d
7 N8c87e8817cb943eb8225061739067aaf
8 N8d16d2484f6846c6bcccb8e6029d56ab
9 N8e5e998f5f1d4347a70cfe6e4cc4e07d
10 N9d3813fc90a242fc93a97e1e8e625890
11 Naa231ad9c2c54d58bab67d67342b02e9
12 Nb44a60581c2147dd8458dbd3a5d4e677
13 Nd24cd9e74b824021969a296860041c9a
14 Nda5455f821bd43268763d36a8ff53651
15 Ne197d3d9cf424cf5b3dfb0195683f83f
16 Nf1ebeaad9e4e4cc9a1adabfdd067dc23
17 Nf8e90dec61084e9298410574157743bd
18 Nfbc42bf233fc416691770676c8a4efd8
19 anzsrc-for:11
20 anzsrc-for:1103
21 schema:author Neb55348f984c4df590e0adc6b110b87a
22 schema:citation sg:pub.10.1007/bf00114219
23 sg:pub.10.1007/bf03324236
24 sg:pub.10.1007/s10238-007-0145-8
25 sg:pub.10.2165/00002512-200724050-00004
26 https://doi.org/10.1001/archderm.144.7.886
27 https://doi.org/10.1001/jama.285.23.2987
28 https://doi.org/10.1002/cncr.24864
29 https://doi.org/10.1002/path.2122
30 https://doi.org/10.1016/0021-9681(87)90171-8
31 https://doi.org/10.1016/j.critrevonc.2008.08.002
32 https://doi.org/10.1016/j.ejca.2007.06.001
33 https://doi.org/10.1016/j.ejca.2007.08.002
34 https://doi.org/10.1016/j.eururo.2006.10.025
35 https://doi.org/10.1016/j.jaad.2006.10.032
36 https://doi.org/10.1016/j.thorsurg.2014.12.003
37 https://doi.org/10.1016/s0749-0690(02)00047-2
38 https://doi.org/10.1016/s0895-4356(99)00098-0
39 https://doi.org/10.1016/s1569-9056(08)60692-2
40 https://doi.org/10.1046/j.1532-5415.51.3s.4.x
41 https://doi.org/10.1056/nejmoa060655
42 https://doi.org/10.1056/nejmra050100
43 https://doi.org/10.1093/geront/9.3_part_1.179
44 https://doi.org/10.1093/jnci/djn319
45 https://doi.org/10.1097/00000658-198910000-00008
46 https://doi.org/10.1097/00004872-200311000-00002
47 https://doi.org/10.1097/00045391-200307000-00010
48 https://doi.org/10.1111/j.1365-2230.2006.02223.x
49 https://doi.org/10.1111/j.1445-5994.2007.01269.x
50 https://doi.org/10.1111/j.1464-410x.2007.07486.x
51 https://doi.org/10.1158/1535-7163.mct-08-0013
52 https://doi.org/10.1159/000227118
53 https://doi.org/10.1177/107327480701400103
54 https://doi.org/10.1188/07.cjon.649-656
55 https://doi.org/10.1200/jco.2005.10.976
56 https://doi.org/10.1200/jco.2007.15.6331
57 https://doi.org/10.1200/jco.2008.19.5511
58 https://doi.org/10.1200/jco.2009.23.4823
59 https://doi.org/10.1634/theoncologist.2008-0131
60 https://doi.org/10.2190/6ncr-8ewf-tvhw-03c7
61 https://doi.org/10.2190/uurl-2ryu-wryd-ey3k
62 https://doi.org/10.3816/cgc.2009.n.003
63 https://doi.org/10.5489/cuaj.67
64 schema:datePublished 2010-12
65 schema:datePublishedReg 2010-12-01
66 schema:description Renal cell carcinoma primarily affects older individuals. Approximately half of all new renal cell carcinoma diagnoses are made in persons 65 years of age or older. Devising a treatment plan for the elderly patient population requires special consideration. Age-related physiological, cognitive, and social characteristics of elderly patients may influence each stage of patient care. Until recently, treatment options were limited for elderly patients with renal cell carcinoma. Sorafenib is the first multikinase inhibitor approved for use in renal cell carcinoma in the United States and Europe. In the phase III Treatment Approaches in Renal Cell Cancer Global Evaluation Trial, sorafenib significantly extended progression-free survival in patients with advanced renal cell carcinoma, regardless of age. Incidence rates of adverse events were not significantly higher in elderly patients receiving sorafenib than in younger patients. Thus, sorafenib represents an important treatment option for elderly patients with renal cell carcinoma. This report describes particular considerations for physicians to be aware of when choosing a treatment regimen for their elderly patients with renal cell carcinoma and offers recommendations on how to integrate specific management strategies into clinical practice that will optimize the use of sorafenib in the elderly. The strategies focus on patient selection, assessment of quality of life, management of adverse events, and appropriate dose modifications. The goal of these recommendations is to maximize the clinical benefit of sorafenib in the elderly patient population through appropriate use.
67 schema:genre research_article
68 schema:inLanguage en
69 schema:isAccessibleForFree false
70 schema:isPartOf N6ab928fcddc84083abd37cd3518791af
71 Nfa3c046340f44931ba712e0821ea9ebb
72 sg:journal.1094524
73 schema:name Experience with sorafenib and the elderly patient
74 schema:pagination 1359-1370
75 schema:productId N127c8bb9575f429ba1e84c4fd8d55269
76 N1bcfa3ed09834c8bb21dae97e865cb84
77 N2e50a0350efd4f9c9181dd3753d85334
78 N6729994aa0b742c5b8a97a9ccbdf5474
79 Ncfa1160bb2c6456e9a2749359a2afc67
80 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002519393
81 https://doi.org/10.1007/s12032-009-9388-4
82 schema:sdDatePublished 2019-04-11T09:57
83 schema:sdLicense https://scigraph.springernature.com/explorer/license/
84 schema:sdPublisher N479fb6898166442ea82edfb906ab264a
85 schema:url http://link.springer.com/10.1007%2Fs12032-009-9388-4
86 sgo:license sg:explorer/license/
87 sgo:sdDataset articles
88 rdf:type schema:ScholarlyArticle
89 N078886f7a28c49118027de64a424f1eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Quality of Life
91 rdf:type schema:DefinedTerm
92 N0c86e6c4f55d47dc9179e698ab59dbfe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Niacinamide
94 rdf:type schema:DefinedTerm
95 N127c8bb9575f429ba1e84c4fd8d55269 schema:name dimensions_id
96 schema:value pub.1002519393
97 rdf:type schema:PropertyValue
98 N1bcfa3ed09834c8bb21dae97e865cb84 schema:name doi
99 schema:value 10.1007/s12032-009-9388-4
100 rdf:type schema:PropertyValue
101 N1ef5dee9b7b04dd0be76a881d80edbdf schema:name Department of Oncology, Montefiore Medical Center-North Division/New York Medical College, 600 East 233rd Street, 10466, Bronx, NY, USA
102 rdf:type schema:Organization
103 N2e50a0350efd4f9c9181dd3753d85334 schema:name readcube_id
104 schema:value 0bfed4032cbdfd35c90d0cd666b692d6a20949bf4c3ac782a1aae64baac82e48
105 rdf:type schema:PropertyValue
106 N43da09f675734fb4baec683531b5f572 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Humans
108 rdf:type schema:DefinedTerm
109 N479fb6898166442ea82edfb906ab264a schema:name Springer Nature - SN SciGraph project
110 rdf:type schema:Organization
111 N57d5122fc74143048bcb0a7cbf27342f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Aged
113 rdf:type schema:DefinedTerm
114 N6689461dc36644e49bf3bdcb6688d8fa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Pyridines
116 rdf:type schema:DefinedTerm
117 N6729994aa0b742c5b8a97a9ccbdf5474 schema:name nlm_unique_id
118 schema:value 9435512
119 rdf:type schema:PropertyValue
120 N6ab928fcddc84083abd37cd3518791af schema:volumeNumber 27
121 rdf:type schema:PublicationVolume
122 N85bddf66b6f54f18b9312509543b478d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Sorafenib
124 rdf:type schema:DefinedTerm
125 N8a0eace8e4234e88a7d41ea7c5341384 rdf:first sg:person.01004561122.13
126 rdf:rest Nbfaf26e7d291404985d0063d74a45ea1
127 N8c87e8817cb943eb8225061739067aaf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Clinical Trials, Phase III as Topic
129 rdf:type schema:DefinedTerm
130 N8d16d2484f6846c6bcccb8e6029d56ab schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Female
132 rdf:type schema:DefinedTerm
133 N8e5e998f5f1d4347a70cfe6e4cc4e07d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Aged, 80 and over
135 rdf:type schema:DefinedTerm
136 N9d3813fc90a242fc93a97e1e8e625890 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Kidney Neoplasms
138 rdf:type schema:DefinedTerm
139 Naa231ad9c2c54d58bab67d67342b02e9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Randomized Controlled Trials as Topic
141 rdf:type schema:DefinedTerm
142 Nb44a60581c2147dd8458dbd3a5d4e677 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Survival Rate
144 rdf:type schema:DefinedTerm
145 Nbfaf26e7d291404985d0063d74a45ea1 rdf:first sg:person.01174264563.01
146 rdf:rest Nd14f0559607f488780019d904f76df49
147 Ncfa1160bb2c6456e9a2749359a2afc67 schema:name pubmed_id
148 schema:value 20043216
149 rdf:type schema:PropertyValue
150 Nd14f0559607f488780019d904f76df49 rdf:first sg:person.01304252172.82
151 rdf:rest rdf:nil
152 Nd24cd9e74b824021969a296860041c9a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Male
154 rdf:type schema:DefinedTerm
155 Nda5455f821bd43268763d36a8ff53651 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Prognosis
157 rdf:type schema:DefinedTerm
158 Ne197d3d9cf424cf5b3dfb0195683f83f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Antineoplastic Agents
160 rdf:type schema:DefinedTerm
161 Neb55348f984c4df590e0adc6b110b87a rdf:first sg:person.0760406720.36
162 rdf:rest N8a0eace8e4234e88a7d41ea7c5341384
163 Nf1ebeaad9e4e4cc9a1adabfdd067dc23 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Benzenesulfonates
165 rdf:type schema:DefinedTerm
166 Nf8e90dec61084e9298410574157743bd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Phenylurea Compounds
168 rdf:type schema:DefinedTerm
169 Nfa3c046340f44931ba712e0821ea9ebb schema:issueNumber 4
170 rdf:type schema:PublicationIssue
171 Nfbc42bf233fc416691770676c8a4efd8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Carcinoma, Renal Cell
173 rdf:type schema:DefinedTerm
174 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
175 schema:name Medical and Health Sciences
176 rdf:type schema:DefinedTerm
177 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
178 schema:name Clinical Sciences
179 rdf:type schema:DefinedTerm
180 sg:journal.1094524 schema:issn 1357-0560
181 1559-131X
182 schema:name Medical Oncology
183 rdf:type schema:Periodical
184 sg:person.01004561122.13 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
185 schema:familyName Tannir
186 schema:givenName Nizar
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01004561122.13
188 rdf:type schema:Person
189 sg:person.01174264563.01 schema:affiliation https://www.grid.ac/institutes/grid.411142.3
190 schema:familyName Bellmunt
191 schema:givenName Joaquim
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174264563.01
193 rdf:type schema:Person
194 sg:person.01304252172.82 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
195 schema:familyName Escudier
196 schema:givenName Bernard
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01304252172.82
198 rdf:type schema:Person
199 sg:person.0760406720.36 schema:affiliation N1ef5dee9b7b04dd0be76a881d80edbdf
200 schema:familyName Dutcher
201 schema:givenName Janice P.
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0760406720.36
203 rdf:type schema:Person
204 sg:pub.10.1007/bf00114219 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018948431
205 https://doi.org/10.1007/bf00114219
206 rdf:type schema:CreativeWork
207 sg:pub.10.1007/bf03324236 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024440962
208 https://doi.org/10.1007/bf03324236
209 rdf:type schema:CreativeWork
210 sg:pub.10.1007/s10238-007-0145-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011346859
211 https://doi.org/10.1007/s10238-007-0145-8
212 rdf:type schema:CreativeWork
213 sg:pub.10.2165/00002512-200724050-00004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015726241
214 https://doi.org/10.2165/00002512-200724050-00004
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1001/archderm.144.7.886 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012999259
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1001/jama.285.23.2987 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043181545
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1002/cncr.24864 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008293686
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1002/path.2122 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021696329
223 rdf:type schema:CreativeWork
224 https://doi.org/10.1016/0021-9681(87)90171-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020988115
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1016/j.critrevonc.2008.08.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041881420
227 rdf:type schema:CreativeWork
228 https://doi.org/10.1016/j.ejca.2007.06.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020678878
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1016/j.ejca.2007.08.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044272511
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1016/j.eururo.2006.10.025 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047365003
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1016/j.jaad.2006.10.032 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049933957
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1016/j.thorsurg.2014.12.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032347522
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1016/s0749-0690(02)00047-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045864790
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1016/s0895-4356(99)00098-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028392244
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1016/s1569-9056(08)60692-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003933990
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1046/j.1532-5415.51.3s.4.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1039042475
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1056/nejmoa060655 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025111240
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1056/nejmra050100 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004833991
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1093/geront/9.3_part_1.179 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059635232
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1093/jnci/djn319 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015009768
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1097/00000658-198910000-00008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003070692
255 rdf:type schema:CreativeWork
256 https://doi.org/10.1097/00004872-200311000-00002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006591110
257 rdf:type schema:CreativeWork
258 https://doi.org/10.1097/00045391-200307000-00010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045019789
259 rdf:type schema:CreativeWork
260 https://doi.org/10.1111/j.1365-2230.2006.02223.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1023690834
261 rdf:type schema:CreativeWork
262 https://doi.org/10.1111/j.1445-5994.2007.01269.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1032610540
263 rdf:type schema:CreativeWork
264 https://doi.org/10.1111/j.1464-410x.2007.07486.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1025646383
265 rdf:type schema:CreativeWork
266 https://doi.org/10.1158/1535-7163.mct-08-0013 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048133345
267 rdf:type schema:CreativeWork
268 https://doi.org/10.1159/000227118 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027938996
269 rdf:type schema:CreativeWork
270 https://doi.org/10.1177/107327480701400103 schema:sameAs https://app.dimensions.ai/details/publication/pub.1077354991
271 rdf:type schema:CreativeWork
272 https://doi.org/10.1188/07.cjon.649-656 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064136236
273 rdf:type schema:CreativeWork
274 https://doi.org/10.1200/jco.2005.10.976 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012142576
275 rdf:type schema:CreativeWork
276 https://doi.org/10.1200/jco.2007.15.6331 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016398351
277 rdf:type schema:CreativeWork
278 https://doi.org/10.1200/jco.2008.19.5511 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017988502
279 rdf:type schema:CreativeWork
280 https://doi.org/10.1200/jco.2009.23.4823 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024805447
281 rdf:type schema:CreativeWork
282 https://doi.org/10.1634/theoncologist.2008-0131 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032131308
283 rdf:type schema:CreativeWork
284 https://doi.org/10.2190/6ncr-8ewf-tvhw-03c7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053989460
285 rdf:type schema:CreativeWork
286 https://doi.org/10.2190/uurl-2ryu-wryd-ey3k schema:sameAs https://app.dimensions.ai/details/publication/pub.1043088486
287 rdf:type schema:CreativeWork
288 https://doi.org/10.3816/cgc.2009.n.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046305670
289 rdf:type schema:CreativeWork
290 https://doi.org/10.5489/cuaj.67 schema:sameAs https://app.dimensions.ai/details/publication/pub.1072921435
291 rdf:type schema:CreativeWork
292 https://www.grid.ac/institutes/grid.14925.3b schema:alternateName Institut Gustave Roussy
293 schema:name Immunotherapy Unit, Institut Gustave Roussy, 94805, Paris, France
294 rdf:type schema:Organization
295 https://www.grid.ac/institutes/grid.240145.6 schema:alternateName The University of Texas MD Anderson Cancer Center
296 schema:name Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, 77030, Houston, TX, USA
297 rdf:type schema:Organization
298 https://www.grid.ac/institutes/grid.411142.3 schema:alternateName Hospital Del Mar
299 schema:name Department of Genitourinary and Gastrointestinal Tumor Oncology, Hospital Del Mar, 08003, Barcelona, Spain
300 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...